Florida SB 1802: Interception of Wire, Oral, or Electronic Communications Made in Violation of Protective Orders

Bill Text

1802 
Tardive Dyskinesia Awareness Week 
2026-02-09T11:58:34Z 
Recognizing the week of May 3, 2026 as “Tardive Dyskinesia Awareness Week” in Florida and expressing the Senate’s support of efforts to raise awareness about the causes, symptoms, and importance of routine screening for tardive dyskinesia, etc. 
Original Filed Version 
2026 
S 
SR 
Resolution 
__ 

 Florida Senate - 2026 (NP) SR 1802 

 By Senator Rodriguez 

 40-02159-26 20261802__ 
 1 Senate Resolution 
 2 A resolution recognizing the week of May 3, 2026 as 
 3 “Tardive Dyskinesia Awareness Week” in Florida and 
 4 expressing the Senate’s support of efforts to raise 
 5 awareness about the causes, symptoms, and importance 
 6 of routine screening for tardive dyskinesia. 
 7 
 8 WHEREAS, such serious mental illnesses as bipolar disorder, 
 9 major depressive disorder, and schizophrenia often require 
 10 treatment with antipsychotic medications for effective 
 11 management, and antipsychotic prescribing rates continue to 
 12 rise, and 
 13 WHEREAS, while prolonged antipsychotic use may be essential 
 14 for the treatment of certain conditions, it is associated with 
 15 tardive dyskinesia (TD), a condition marked by uncontrollable, 
 16 abnormal, and repetitive movements of the face, torso, limbs, or 
 17 extremities, and 
 18 WHEREAS, people at higher risk of TD include those older 
 19 than 55 years of age; black individuals; women; individuals with 
 20 mood or substance use disorders, intellectual disabilities, or 
 21 central nervous system injuries; and those with high cumulative 
 22 antipsychotic exposure, and 
 23 WHEREAS, approximately 60 percent of the estimated 800,000 
 24 U.S. adults living with TD remain undiagnosed, and even mild TD 
 25 symptoms can be stigmatizing and impair physical, social, and 
 26 emotional well-being, underscoring the urgency of early 
 27 screening, detection, and intervention, and 
 28 WHEREAS, the American Psychiatric Association recommends 
 29 routine TD screening in its clinical guidelines for 
 30 antipsychotic treatment, and individuals treated with 
 31 antipsychotics or experiencing abnormal movements should consult 
 32 their health care providers to assess TD risk, receive TD 
 33 screenings, and determine appropriate treatment, and 
 34 WHEREAS, treatments approved by the United States Food and 
 35 Drug Administration for TD can provide options for symptom 
 36 management and improved quality of life for many individuals 
 37 living with TD, and 
 38 WHEREAS, education and awareness for health care providers, 
 39 patients, and care partners can help ensure patients prescribed 
 40 antipsychotics receive care and support that aligns with 
 41 clinical best practices, including regular TD screenings, NOW, 
 42 THEREFORE, 
 43 
 44 Be It Resolved by the Senate of the State of Florida: 
 45 
 46 That the week of May 3, 2026 is recognized as “Tardive 
 47 Dyskinesia Awareness Week” in Florida, and that the Senate 
 48 expresses its support of efforts to raise awareness about the 
 49 causes, symptoms, and importance of routine screening for 
 50 tardive dyskinesia.